TITLE

Safeguarding integrity in research collaborations: possible strategies

AUTHOR(S)
Khajuria, Ankur; Agha, Riaz A.
PUB. DATE
June 2014
SOURCE
British Journal of Hospital Medicine (17508460);Jun2014, Vol. 75 Issue 6, p354
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter to the Editor
ABSTRACT
A letter to the editor is presented which notes how governments worldwide are putting greater scrutiny on research integrity and quality assurance and suggests enforcing robust measures to deal with misconduct.
ACCESSION #
96939994

 

Related Articles

  • Open Your Mind to Research. Cambron, Jerrilyn // Massage & Bodywork;Sep/Oct2013, Vol. 28 Issue 5, p52 

    The article discusses the importance of incorporating knowledge from research in the practice by massage therapy community. It mentions that massage therapy research continues to grow each year with articles about the efficacy of massage therapy which can help to strengthen the practice along...

  • Collaborative clinician-led research networks. SIMPSON, ROSALIND; LAYFIELD, CARRON; WILLIAMS, HYWEL // Clinical Medicine;Dec2014, Vol. 14 Issue 6, p691 

    A letter to the editor is presented in response to an article in the April 2014 issue on the Northern Region Endoscopy Group (NREG) which is stated to be similar to the UK Dermatology Clinical Trials Network (UK DCTN).

  • Need for clinical research in children. Wright, Katharine // BMJ: British Medical Journal;1/9/2016, Vol. 352 Issue 8039, ph6902 

    A letter to the editor is presented in response to the article "This week," in the December 5, 2015 issue.

  • Tourette syndrome research in Europe has entered a new era of collaboration. Hoekstra, Pieter; Dietrich, Andrea // European Child & Adolescent Psychiatry;Feb2015, Vol. 24 Issue 2, p125 

    An introduction is presented in which the editor discusses various reports within the issue including the tourette syndrome (TS) research, the divergence in TS research findings, and the set up of the Tourette International Collaborative Genetics research.

  • Considering Actionability at the Participant's Research Setting Level for Anticipatable Incidental Findings from Clinical Research. Ortiz-Osorno, Alberto (Betto); Ehler, Linda A.; Brooks, Judith // Journal of Law, Medicine & Ethics;Fall2015, Vol. 43 Issue 3, p619 

    Determining what constitutes an anticipatable incidental finding (IF) from clinical research and defining whether, and when, this IF should be returned to the participant have been topics of discussion in the field of human subject protections for the last 10 years. It has been debated that...

  • Translational Tinnitus Research. Bauer, Carol // Audiology Today;Jul/Aug2011, Vol. 23 Issue 4, p62 

    The article focuses on translational research regarding the treatment of tinnitus, a complex hearing problem. It mentions that translational research combines clinical findings and results from laboratories, which is not a one way flow of information. It states that accurate observations and...

  • Developing a clinical research network: The Northern Region Endoscopy Group experience. Rajasekhar, Praveen; Rees, Colin; Rutter, Matthew; Hungin, Pali // Clinical Medicine;Apr2014, Vol. 14 Issue 2, p107 

    Research is central to the National Health Service. Clinical trial recruitment has been aided by the National Institute for Health Research's Comprehensive Research Network but these networks do not support development of research. The Northern Region Endoscopy Group (NREG) was founded in 2007,...

  • The Tourette International Collaborative Genetics (TIC Genetics) study, finding the genes causing Tourette syndrome: objectives and methods. Dietrich, Andrea; Fernandez, Thomas; King, Robert; State, Matthew; Tischfield, Jay; Hoekstra, Pieter; Heiman, Gary // European Child & Adolescent Psychiatry;Feb2015, Vol. 24 Issue 2, p141 

    Tourette syndrome (TS) is a neuropsychiatric disorder characterized by recurrent motor and vocal tics, often accompanied by obsessive-compulsive disorder and/or attention-deficit/hyperactivity disorder. While the evidence for a genetic contribution is strong, its exact nature has yet to be...

  • Company teams with researchers on hyperoxaluria Tx trial.  // Urology Times;May2019, Vol. 47 Issue 5, p31 

    The article reports on the agreement announced by Allena Pharmaceuticals, Inc. with the Duke Clinical Research Institute (DCRI) in Durham, North Carolina to support the URIROX-2 phase III clinical trial of reloxaliase in enteric hyperoxaluria, as of May 2019.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics